$CUE
Cue Biopharma, Inc.

2019 Form 10-K Financial Statement

#000156459020010212 Filed on March 12, 2020

View on sec.gov

Income Statement

Concept 2019 2018 Q4 2018
Revenue $3.458M $330.0K $1.143M
YoY Change 202.67%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $12.68M $4.460M $11.26M
YoY Change 12.61% 216.31% 160.65%
% of Gross Profit
Research & Development $27.49M $6.630M $28.54M
YoY Change -3.7% -25.51% 51.02%
% of Gross Profit
Depreciation & Amortization $799.1K $200.0K $760.0K
YoY Change 5.15% 53.85% 81.14%
% of Gross Profit
Operating Expenses $40.23M $11.30M $39.84M
YoY Change 0.97% 8.24% 110.79%
Operating Profit -$38.70M
YoY Change
Interest Expense $482.8K $100.0K $376.0K
YoY Change 28.4% 1074208.57%
% of Operating Profit
Other Income/Expense, Net $482.8K $70.00K $541.3K
YoY Change -10.82% 1546600.0%
Pretax Income -$36.29M -$10.80M -$38.16M
YoY Change -4.9% 3.45% 64.22%
Income Tax $412.5K $830.0K $825.0K
% Of Pretax Income
Net Earnings -$36.70M -$11.62M -$38.98M
YoY Change -5.85% 11.3% 67.8%
Net Earnings / Revenue -1061.18% -3521.21% -3411.53%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.665M -$575.2K -$1.936M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2019 2018 Q4 2018
SHORT-TERM ASSETS
Cash & Short-Term Investments $59.41M $39.21M $39.26M
YoY Change 51.32% -38.28% -38.25%
Cash & Equivalents $44.29M $20.80M $20.80M
Short-Term Investments $15.12M $18.41M $18.46M
Other Short-Term Assets $860.0K $1.300M $1.350M
YoY Change -36.3% -13.33% -8.78%
Inventory
Prepaid Expenses
Receivables $750.0K
Other Receivables $0.00
Total Short-Term Assets $61.02M $40.61M $40.61M
YoY Change 50.26% -37.59% -37.59%
LONG-TERM ASSETS
Property, Plant & Equipment $7.180M $2.781M $2.780M
YoY Change 158.27% 64.53% 64.5%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.400M $808.7K $1.970M
YoY Change 72.59% 307.87%
Total Long-Term Assets $10.59M $4.753M $4.750M
YoY Change 122.95% 151.64% 152.66%
TOTAL ASSETS
Total Short-Term Assets $61.02M $40.61M $40.61M
Total Long-Term Assets $10.59M $4.753M $4.750M
Total Assets $71.61M $45.36M $45.36M
YoY Change 57.87% -32.25% -32.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $880.0K $2.035M $2.040M
YoY Change -56.86% 22.67% 53.38%
Accrued Expenses $6.410M $1.788M $1.480M
YoY Change 333.11% 55.34% 72.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $11.66M $6.217M $6.220M
YoY Change 87.46% 16.28% 16.26%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.370M $5.200M $5.170M
YoY Change 3.87%
Total Long-Term Liabilities $5.370M $5.200M $5.170M
YoY Change 3.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.66M $6.217M $6.220M
Total Long-Term Liabilities $5.370M $5.200M $5.170M
Total Liabilities $17.02M $11.39M $11.39M
YoY Change 49.43% 113.05% 112.9%
SHAREHOLDERS EQUITY
Retained Earnings -$71.80M
YoY Change 118.77%
Common Stock $105.8M
YoY Change 12.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $54.58M $33.97M $33.97M
YoY Change
Total Liabilities & Shareholders Equity $71.61M $45.36M $45.36M
YoY Change 57.87% -32.25% -32.25%

Cashflow Statement

Concept 2019 2018 Q4 2018
OPERATING ACTIVITIES
Net Income -$36.70M -$11.62M -$38.98M
YoY Change -5.85% 11.3% 67.8%
Depreciation, Depletion And Amortization $799.1K $200.0K $760.0K
YoY Change 5.15% 53.85% 81.14%
Cash From Operating Activities -$30.80M -$3.900M -$26.41M
YoY Change 16.61% 106.35% 116.66%
INVESTING ACTIVITIES
Capital Expenditures $46.35K -$120.0K $1.854M
YoY Change -97.5% 1100.0% 80.03%
Acquisitions
YoY Change
Other Investing Activities $3.490M $4.810M -$18.50M
YoY Change -118.86%
Cash From Investing Activities $3.447M $4.690M -$20.35M
YoY Change -116.93% -47000.0% 1589.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$48.91M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 50.79M 4.170M 4.182M
YoY Change 1114.53% -93.28% -93.26%
NET CHANGE
Cash From Operating Activities -30.80M -3.900M -26.41M
Cash From Investing Activities 3.447M 4.690M -20.35M
Cash From Financing Activities 50.79M 4.170M 4.182M
Net Change In Cash 23.44M 4.960M -42.58M
YoY Change -155.04% -91.75% -187.52%
FREE CASH FLOW
Cash From Operating Activities -$30.80M -$3.900M -$26.41M
Capital Expenditures $46.35K -$120.0K $1.854M
Free Cash Flow -$30.84M -$3.780M -$28.27M
YoY Change 9.12% 101.06% 113.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28544051
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27487485
CY2019 us-gaap Operating Expenses
OperatingExpenses
40227578
CY2018 us-gaap Operating Expenses
OperatingExpenses
39839262
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
20697
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
105762891
CY2019 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2019 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2019 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-3324577
CY2019 dei Entity Address Address Line1
EntityAddressAddressLine1
21 Erie Street Cambridge
CY2019 dei Document Annual Report
DocumentAnnualReport
true
CY2019 dei Document Transition Report
DocumentTransitionReport
false
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44290030
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20800284
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
15119925
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
18412500
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
754898
CY2018Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
50068
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
860107
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1347288
CY2019Q4 us-gaap Assets Current
AssetsCurrent
61024960
CY2018Q4 us-gaap Assets Current
AssetsCurrent
40610140
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1846922
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2781459
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5337026
CY2019Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
2572476
CY2018Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
1012772
CY2019Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
150000
CY2018Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
150000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
673625
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
808729
CY2019Q4 us-gaap Assets
Assets
71605009
CY2018Q4 us-gaap Assets
Assets
45363100
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
882666
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2035354
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2227352
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1788062
CY2019Q4 cue Research And Development Contract Liability Current
ResearchAndDevelopmentContractLiabilityCurrent
4097443
CY2018Q4 cue Research And Development Contract Liability Current
ResearchAndDevelopmentContractLiabilityCurrent
2011998
CY2018Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
381465
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4447787
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11655248
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6216879
CY2019Q4 cue Research And Development Contract Liability Noncurrent
ResearchAndDevelopmentContractLiabilityNoncurrent
4017894
CY2018Q4 cue Research And Development Contract Liability Noncurrent
ResearchAndDevelopmentContractLiabilityNoncurrent
5174752
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1347971
CY2018Q4 us-gaap Liabilities
Liabilities
11391631
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10958
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71801161
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
33971469
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
45363100
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018 cue Increase Decrease In Research And Development Contract Liability
IncreaseDecreaseInResearchAndDevelopmentContractLiability
4686750
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20697453
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20697453
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22041792
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20134065
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
61607178
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4169349
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7173713
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12500
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
64078
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
165337
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
482790
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
541345
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36286457
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38155313
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
412500
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
825000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-36698957
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-38980313
CY2018 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-10958
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-36698320
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-38991271
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.66
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.94
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10958
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
48998907
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6520982
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
12
CY2019 us-gaap Restricted Stock Award Forfeitures
RestrictedStockAwardForfeitures
91027
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
637
CY2019 us-gaap Profit Loss
ProfitLoss
-36698957
CY2018 us-gaap Profit Loss
ProfitLoss
-38980313
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
810782
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
760011
CY2018 cue Operating Lease Rent Payments
OperatingLeaseRentPayments
-345101
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
6520982
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
7173713
CY2019 cue Operating Lease Right Of Use Amortization
OperatingLeaseRightOfUseAmortization
4354810
CY2019 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-54274
CY2018 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-3315
CY2019 cue Non Cash Investment Income
NonCashInvestmentIncome
72464
CY2018 cue Non Cash Investment Income
NonCashInvestmentIncome
-76544
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
754898
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-487182
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
701939
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-123437
CY2019 cue Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-4277544
CY2019 cue Increase Decrease In Deposit Liabilities
IncreaseDecreaseInDepositLiabilities
-1559704
CY2018 cue Increase Decrease In Deposit Liabilities
IncreaseDecreaseInDepositLiabilities
-787272
CY2019 cue Increase Decrease In Research And Development Contract Liability
IncreaseDecreaseInResearchAndDevelopmentContractLiability
928588
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
439290
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
636975
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1152688
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
376147
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30796910
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26410968
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
46353
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1854246
CY2019 cue Payments For Redemption Of Short Term Investments
PaymentsForRedemptionOfShortTermInvestments
-18500000
CY2018 cue Payments For Redemption Of Short Term Investments
PaymentsForRedemptionOfShortTermInvestments
-21000000
CY2019 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
15134324
CY2018 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
39500000
CY2019 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
127500
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3446823
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20354246
CY2019 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
48998907
CY2018 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
4169349
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
91027
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1881873
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12500
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
50789765
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4181849
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
23439678
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-42583365
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21000352
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
63583717
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
44440030
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
412500
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
825000
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:10pt;text-indent:5.48%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates include estimates related to revenue, the accounting for potential liabilities and accrued expenses, the assumptions utilized in valuing stock-based compensation issued for services, the realization of deferred tax assets, and the useful life with respect to long-lived assets and intangibles. Actual results could differ from those estimates.</p>
CY2019Q4 cue Fair Value Assets Among Level2 And Level3 Transfers Amount
FairValueAssetsAmongLevel2AndLevel3TransfersAmount
0
CY2018Q4 cue Fair Value Assets Among Level2 And Level3 Transfers Amount
FairValueAssetsAmongLevel2AndLevel3TransfersAmount
0
CY2019 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2014-12-31
CY2019Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
59409955
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
150000
CY2018Q4 us-gaap Restricted Cash
RestrictedCash
150000
CY2019 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P14Y
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11668
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6049747
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5792762
CY2019Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
39303609
CY2018Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
10547628
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
15119925
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
18412500
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
15130246
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
18423458
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
10321
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
10958
CY2018 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
612
CY2019 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
637
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3872972
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4147398
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2026050
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1365939
CY2019 us-gaap Depreciation
Depreciation
799114
CY2018 us-gaap Depreciation
Depreciation
760011
CY2019Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1575821
CY2018Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1195749
CY2019Q4 cue Accrued Contract Manufacturing Services Current
AccruedContractManufacturingServicesCurrent
150250
CY2018Q4 cue Accrued Contract Manufacturing Services Current
AccruedContractManufacturingServicesCurrent
160650
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
383910
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
207440
CY2019Q4 cue Accrued Contract Research Services Current
AccruedContractResearchServicesCurrent
117371
CY2018Q4 cue Accrued Contract Research Services Current
AccruedContractResearchServicesCurrent
145035
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
79188
CY2019Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
465105
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0175
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0243
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0258
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0295
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.880
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.820
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.940
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.836
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2732221
CY2019 cue Share Based Compensation Arrangement By Share Based Payment Award Fair Value Of Options Market Close Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfOptionsMarketClosePrice
15.88
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
19471155
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1682014
CY2019Q4 cue Share Based Compensation Arrangement By Share Based Payment Award Fair Value Of Options Exercisable Intrinsic Fair Value Per Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfOptionsExercisableIntrinsicFairValuePerShare
6.26
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1835600
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2500
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
25000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4540321
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1288100
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
485105
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
550063
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4793253
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2025858
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.07
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.33
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.00
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.79
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.08
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.10
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.26
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M3D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y1M28D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y7M20D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y5M19D
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
12211819
CY2018Q4 cue Share Based Compensation Arrangement By Share Based Payment Award Fair Value Of Options Exercisable Intrinsic Fair Value Per Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfOptionsExercisableIntrinsicFairValuePerShare
4.70
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6520982
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7173713
CY2019 cue Number Of Tranches
NumberOfTranches
2
CY2019Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2500000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
23348000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
15738000
CY2019Q4 cue Deferred Tax Assets Tax Credit Carryforwards Research And Other
DeferredTaxAssetsTaxCreditCarryforwardsResearchAndOther
2069000
CY2018Q4 cue Deferred Tax Assets Tax Credit Carryforwards Research And Other
DeferredTaxAssetsTaxCreditCarryforwardsResearchAndOther
1450000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
5281000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1953000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3000
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
30701000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
19144000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
29095000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19004000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1606000
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
140000
CY2019Q4 cue Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
-1606000
CY2018Q4 cue Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
140000
CY2019 cue Deferred Tax Assets Valuation Allowance Percentage
DeferredTaxAssetsValuationAllowancePercentage
1.00
CY2018 cue Deferred Tax Assets Valuation Allowance Percentage
DeferredTaxAssetsValuationAllowancePercentage
1.00
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.06
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.04
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.27
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.24
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.02
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.02
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.01
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.03
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.00
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.00
CY2019 cue Effective Income Tax Rate Reconciliation Foreign Withholding Taxes
EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxes
0.01
CY2018 cue Effective Income Tax Rate Reconciliation Foreign Withholding Taxes
EffectiveIncomeTaxRateReconciliationForeignWithholdingTaxes
0.02
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.01
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.00
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.01
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.02
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
972000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
510000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
294000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
430000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
81000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
32000
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
13000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1334000
CY2018 us-gaap Description Of Lessee Leasing Arrangements Operating Leases
DescriptionOfLesseeLeasingArrangementsOperatingLeases
Upon execution of this lease agreement the Company prepaid three months of rent, two of which will be held in escrow and credited against future rent payments and one month that was applied to the first months rent. The Company also prepaid seven and one half months rent pursuant to an amendment to the lease agreement executed on June 18, 2018. These amounts were recorded to deposits and prepaid expenses, respectively at December 31, 2018
CY2018 cue Additional Description Of Lessee Leasing Arrangements Operating Leases
AdditionalDescriptionOfLesseeLeasingArrangementsOperatingLeases
Upon execution of this lease agreement the Company prepaid three months of rent which will be held in escrow and credited against future rent payments. The monthly rental rate under the lease agreement is $72,600 for the first 12 months and $78,600 for the remainder of the term. Upon execution of this lease agreement the Company prepaid twelve months rent pursuant to the lease agreement executed on September 20, 2018.
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
4674540
CY2019Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1363408
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6037948
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
242190
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
5795758
CY2019 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
4474000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
3311000

Files In Submission

Name View Source Status
0001564590-20-010212-index-headers.html Edgar Link pending
0001564590-20-010212-index.html Edgar Link pending
0001564590-20-010212.txt Edgar Link pending
0001564590-20-010212-xbrl.zip Edgar Link pending
cue-10k_20191231.htm Edgar Link pending
cue-20191231.xml Edgar Link completed
cue-20191231.xsd Edgar Link pending
cue-20191231_cal.xml Edgar Link unprocessable
cue-20191231_def.xml Edgar Link unprocessable
cue-20191231_lab.xml Edgar Link unprocessable
cue-20191231_pre.xml Edgar Link unprocessable
cue-ex1016_460.htm Edgar Link pending
cue-ex21_6.htm Edgar Link pending
cue-ex231_7.htm Edgar Link pending
cue-ex311_10.htm Edgar Link pending
cue-ex312_11.htm Edgar Link pending
cue-ex321_12.htm Edgar Link pending
cue-ex44_461.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
girq1bltubr1000001.jpg Edgar Link pending
girq1bltubr1000002.jpg Edgar Link pending
girq1bltubr1000003.jpg Edgar Link pending
girq1bltubr1000004.jpg Edgar Link pending
girq1bltubr1000005.jpg Edgar Link pending
girq1bltubr1000006.jpg Edgar Link pending
girq1bltubr1000007.jpg Edgar Link pending
girq1bltubr1000008.jpg Edgar Link pending
girq1bltubr1000009.jpg Edgar Link pending
girq1bltubr1000010.jpg Edgar Link pending
girq1bltubr1000011.jpg Edgar Link pending
girq1bltubr1000012.jpg Edgar Link pending
girq1bltubr1000013.jpg Edgar Link pending
girq1bltubr1000014.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending